Antiangiogenic and hypolipidemic activity of coenzyme Q10 supplementation to breast cancer patients undergoing Tamoxifen therapy

@article{Sachdanandam2008AntiangiogenicAH,
  title={Antiangiogenic and hypolipidemic activity of coenzyme Q10 supplementation to breast cancer patients undergoing Tamoxifen therapy},
  author={P. Sachdanandam},
  journal={BioFactors},
  year={2008},
  volume={32}
}
Tamoxifen, a non‐steroidal anti‐estrogen is now widely used and has led to an increase in both disease‐free and overall survival of women after primary surgery. Tamoxifen therapy is found to cause hypertriglyceridemia by reducing activity of lipolytic enzymes on triglycerides, and thereby increasing the risk of cardiovascular disease. Angiogenesis promotes local tumour progression and invasion and enables tumour cell dissemination and metastasis formation. Our study has found that co… Expand
Coenzyme Q10 in breast cancer care.
Exogenous coenzyme Q10 modulates MMP-2 activity in MCF-7 cell line as a breast cancer cellular model
...
1
2
3
...

References

SHOWING 1-10 OF 52 REFERENCES
Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases.
Survival of cancer patients on therapy with coenzyme Q10.
Interaction of tamoxifen with the multidrug resistance P-glycoprotein.
...
1
2
3
4
5
...